cultured 95 BC organoids from 155 surgical BC tissues and successfully established the pioneering BC organoid repository; they observed that the histopathology and hormone receptor status of BC organoids were similar to those of the original tumor; furthermore, they noted that BC organoids can be used for in vitro drug screening and respond similarly as in vivo xenografts and patients (19). Here, NR4A1 is linked to breast cancer.